Literature DB >> 23538298

The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.

Daniela Hartmann1, Marthe-Susanna Wegner, Ruth Anna Wanger, Nerea Ferreirós, Yannick Schreiber, Jessica Lucks, Susanne Schiffmann, Gerd Geisslinger, Sabine Grösch.   

Abstract

Ceramides are synthesized by six different ceramide synthases (CerS1-6), which differ in their specificity to produce ceramides of distinct chain length. We investigated the impact of CerS-co-transfection on ceramide production and apoptosis and proliferation in HCT-116 cells. Over-expression of CerS4 and CerS6 enhanced the level of C(16:0)-Cer twofold, that of C(18:0)- and C(20:0)-Cer up to sevenfold, in comparison to vector control transfected cells, whereas over-expression of CerS2 had no effect on the level of very long chain ceramide C(24:0)- and C(24:1)-Cer. Instead over-expression of CerS2 together with CerS4 or CerS6 increased the activity of CerS2 against very-long-chain ceramides about twofold. In contrast, co-expression of CerS4 with CerS6 inhibited slightly the production of C20:0-ceramide in comparison to cells over-expressing CerS4 alone, whereas the activity of CerS6 seemed not to be affected by other CerS. Interestingly, down-regulation of ELOVL1 had a comprehensive effect on the synthesis of very long chain ceramides which possibly point to a requirement for ELOVL1 expression for full CerS2-activity. Co-expression of CerS2 with CerS4/CerS6 reversed the inhibitory effect of long chain ceramides on cell proliferation and the induction of apoptosis. Even though we observed a twofold increase in total ceramide levels after co-expression of CerS2 with CerS4/CerS6, we detected no effect on cell proliferation. These data indicate that an increase in ceramide production per se is not critical for cell survival, but the equilibrium between long and very long chain ceramides and possibly protein/protein interactions determine the fate of the cell.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538298     DOI: 10.1016/j.biocel.2013.03.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  23 in total

1.  Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity.

Authors:  Stephanie Oertel; Klaus Scholich; Andreas Weigert; Dominique Thomas; Julia Schmetzer; Sandra Trautmann; Marthe-Susanna Wegner; Heinfried H Radeke; Natalie Filmann; Bernhard Brüne; Gerd Geisslinger; Irmgard Tegeder; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

Review 2.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

3.  Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.

Authors:  Morgan Stathem; Subathra Marimuthu; Julie O'Neal; Jeffrey C Rathmell; Jason A Chesney; Levi J Beverly; Leah J Siskind
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

4.  Ceramide synthase 4 regulates stem cell homeostasis and hair follicle cycling.

Authors:  Franziska Peters; Susanne Vorhagen; Susanne Brodesser; Kristin Jakobshagen; Jens C Brüning; Carien M Niessen; Martin Krönke
Journal:  J Invest Dermatol       Date:  2015-02-23       Impact factor: 8.551

5.  Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study.

Authors:  Samar M Hammad; Nathaniel L Baker; Jad M El Abiad; Stefanka D Spassieva; Jason S Pierce; Barbara Rembiesa; Jacek Bielawski; Maria F Lopes-Virella; Richard L Klein
Journal:  Neuromolecular Med       Date:  2016-07-07       Impact factor: 3.843

6.  UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.

Authors:  Marthe-Susanna Wegner; Nina Schömel; Lisa Gruber; Stephanie Beatrice Örtel; Matti Aleksi Kjellberg; Peter Mattjus; Jennifer Kurz; Sandra Trautmann; Bing Peng; Martin Wegner; Manuel Kaulich; Robert Ahrends; Gerd Geisslinger; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

7.  Multiple genetic programs contribute to CD4 T cell memory differentiation and longevity by maintaining T cell quiescence.

Authors:  Nianbin Song; Srona Sengupta; Stanislav Khoruzhenko; Robin A Welsh; AeRyon Kim; Mithra R Kumar; Søren Ulrik Sønder; John-William Sidhom; Hao Zhang; Chunfa Jie; Robert F Siliciano; Scheherazade Sadegh-Nasseri
Journal:  Cell Immunol       Date:  2020-09-05       Impact factor: 4.868

8.  Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.

Authors:  Richard L Klein; Samar M Hammad; Nathaniel L Baker; Kelly J Hunt; Mohammed M Al Gadban; Patricia A Cleary; Gabriel Virella; Maria F Lopes-Virella
Journal:  Metabolism       Date:  2014-07-09       Impact factor: 8.694

9.  Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging.

Authors:  Alexandra M V Wennberg; Marissa J Schafer; Nathan K LeBrasseur; Rodolfo Savica; Hai H Bui; Clinton E Hagen; John H Hollman; Ronald C Petersen; Michelle M Mielke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

10.  Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.

Authors:  Jessica S Ross; Sarah B Russo; Georgia C Chavis; Lauren A Cowart
Journal:  Clin Lipidol       Date:  2017-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.